Our data demonstrate that there is a clear difference between patients with early RA and HC, with a decrease in CD8+ cytotoxic T cells, CD3+CD56+CD16+ activated T cells, memory B cells and activated B cells in patients with early RA. This evidence concerns the gene NCAM1 and rheumatoid arthritis.